Publications
2011
Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011 Aug 11;365(6):506-17.
Gielen M, Mesotten D, Brugts M, Coopmans W, Van Herck E, Vanhorebeek I, Baxter R, Lamberts S, Janssen JA, Van den Berghe G. Effect of intensive insulin therapy on the somatotropic axis of critically ill children. J Clin Endocrinol Metab. 2011 Aug;96(8):2558-66. Epub 2011 Jun 1
Vanpee G, Segers J, Van Mechelen H, Wouters P, Van den Berghe G, Hermans G, Gosselink R. The interobserver agreement of handheld dynamometry for muscle strength assessment in critically ill patients. Crit Care Med. 2011 Aug;39(8):1929-34.
Van den Berghe G.Coronary bypass surgery: protective effects of insulin or of prevention of hyperglycemia, or both? J Clin Endocrinol Metab. 2011 May;96(5):1272-5.
Van Herpe T, Gielen M, Vanhonsebrouck K, Wouters PJ, Van den Berghe G, De Moor B, Mesotten D. Assessment of blood glucose control in the pediatric intensive care unit: extension of the glycemic penalty index toward children and infants. J Diabetes Sci Technol. 2011 Mar 1;5(2):353-7.
Meyfroidt G, Ingels C, Van den Berghe G. Glycemic control in the ICU. N Engl J Med. 2011 Mar 31;364(13):1280; author reply 1281.
Meyfroidt G, Wouters P, De Becker W, Cottem D, Van den Berghe G. Impact of a computer-generated alert system on the quality of tight glycemic control. Intensive Care Med. 2011 Jul;37(7):1151-7. Epub 2011 Mar 3.
Vanhorebeek I, Gunst J, Derde S, Derese I, Boussemaere M, Güiza F, Martinet W, Timmermans JP, D'Hoore A, Wouters PJ, Van den Berghe G. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J Clin Endocrinol Metab. 2011 Apr;96(4):E633-45. Epub 2011 Jan 26.
Casaer MP, Hermans G, Wilmer A, Van den Berghe G.Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial.Trials. 2011 Jan 24;12:21.
2010
International recommendations for glucose control in adult non diabetic critically ill patients. Ichai C, Preiser JC; Société Française d'Anesthésie-Réanimation; Société de Réanimation de langue Française; Experts group. Crit Care. 2010;14(5):R166. Epub 2010 Sep 14.
Glucose dysregulation and neurological injury biomarkers in critically ill children. Vanhorebeek I, Gielen M, Boussemaere M, Wouters PJ, Grandas FG, Mesotten D, Van den Berghe G. J Clin Endocrinol Metab. 2010 Oct;95(10):4669-79. Epub 2010 Jul 28.
Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery.Vlasselaers D, Mesotten D, Langouche L, Vanhorebeek I, van den Heuvel I, Milants I, Wouters P, Wouters P, Meyns B, Bjerre M, Hansen TK, Van den Berghe G. Ann Thorac Surg. 2010 Jul;90(1):22-9.
Blood glucose control in the intensive care unit: benefits and risks. Gunst J, Van den Berghe G. Semin Dial. 2010 Mar-Apr;23(2):157-62. Review.
Prediction of clinical conditions after coronary bypass surgery using dynamic data analysis. Van Loon K, Guiza F, Meyfroidt G, Aerts JM, Ramon J, Blockeel H, Bruynooghe M, Van den Berghe G, Berckmans D. J Med Syst. 2010 Jun;34(3):229-39.
Alterations in adipose tissue during critical illness: An adaptive and protective response? Langouche L, Perre SV, Thiessen S, Gunst J, Hermans G, D'Hoore A, Kola B, Korbonits M, Van den Berghe G. Am J Respir Crit Care Med. 2010 Aug 15;182(4):507-16. Epub 2010 May 4.
The impact of resuscitated fecal peritonitis on the expression of the hepatic bile salt transporters in a porcine model. Wauters J, Mesotten D, Van Zwam K, van Pelt J, Thiessen S, Dieudonné AS, Vanderborght S, Van den Berghe G, Wilmer A. Shock. 2010 Mar 30. [Epub ahead of print]
Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G. Crit Care Med. 2010 Apr;38(4):1021-9.
Should glucocorticoid-induced hyperglycemia be treated in patients with septic shock? Van den Berghe G. JAMA. 2010 Jan 27;303(4):365-6. No abstract available.
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I, Vahanian A, Auricchio A, Bax JJ, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearn P, McDonag T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, De Caterina R, Agewall S, Al Attar N, Andreotti F, Anker SD, Baron-Esquivias G, Berkenboom G, Chapoutot L, Cifkova R, Faggiano P, Gibbs S, Hansen HS, Iserin L, Israel CW, Kornowski R, Eizagaechevarria NM, Pepi M, Piepoli M, Priebe HJ, Scherer M, Stepinska J, Taggart D, Tubaro M; Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of European Society of Cardiology (ESC); European Society of Anaesthesiology (ESA). Eur J Anaesthesiol. 2010 Feb;27(2):92-137. No abstract available.
Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits. Derde S, Vanhorebeek I, Ververs EJ, Vanhees I, Darras VM, Van Herck E, Larsson L, Van den Berghe G. Crit Care Med. 2010 Feb;38(2):602-11.
2009
Metabolic aspects of critical illness polyneuromyopathy. Hermans G, Vanhorebeek I, Derde S, Van den Berghe G. Crit Care Med. 2009 Oct;37(10 Suppl):S391-7. Review.
Clinical benefits of tight glycaemic control: focus on the intensive care unit. Mesotten D, Van den Berghe G. Best Pract Res Clin Anaesthesiol. 2009 Dec;23(4):421-9. Review.
Tight glycaemic control: from bed to bench and back. Ellger B, Van den Berghe G. Best Pract Res Clin Anaesthesiol. 2009 Dec;23(4):vii-ix. No abstract available.
The hypothalamus-pituitary-thyroid axis in critical illness. Mebis L, van den Berghe G. Neth J Med. 2009 Nov;67(10):332-40. Review.
Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness. Mebis L, Debaveye Y, Ellger B, Derde S, Ververs EJ, Langouche L, Darras VM, Fliers E, Visser TJ, Van den Berghe G. Crit Care. 2009;13(5):R147.
Dynamic data analysis and data mining for prediction of clinical stability. Van Loon K, Guiza F, Meyfroidt G, Aerts JM, Ramon J, Blockeel H, Bruynooghe M, Van Den Berghe G, Berckmans D. Stud Health Technol Inform. 2009;150:590-4.
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I; Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery, European Society of Cardiology; European Society of Anaesthesiology. Eur Heart J. 2009 Nov;30(22):2769-812. Epub 2009 Aug 27. No abstract available.
Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Langouche L, Vander Perre S, Frystyk J, Flyvbjerg A, Hansen TK, Van den Berghe G. Crit Care. 2009;13(4):R112.
Glucose control in critically ill patients. Van den Berghe G, Bouillon R, Mesotten D. N Engl J Med. 2009 Jul 2;361(1):89; author reply 91-2.
The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients. Richir MC, Ellger B, Teerlink T, Siroen MP, Visser M, Spreeuwenberg M, Girbes AR, van der Hoven B, van den Berghe G, Wilhelm AJ, de Vries TP, van Leeuwen PA. Pharmacol Res. 2009 Dec;60(6):519-24.
Hyperglycemic kidney damage in an animal model of prolonged critical illness. Vanhorebeek I, Gunst J, Ellger B, Boussemaere M, Lerut E, Debaveye Y, Rabbani N, Thornalley PJ, Schetz M, Van den Berghe G. Kidney Int. 2009 Sep;76(5):512-20.
Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. J Clin Endocrinol Metab. 2009 Sep;94(9):3163-70.
ESPEN Guidelines on Parenteral Nutrition: intensive care. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN. Clin Nutr. 2009 Aug;28(4):387-400. Epub 2009 Jun 7.PMID: 19505748
Towards closed-loop glycaemic control. Van Herpe T, De Moor B, Van den Berghe G.Best Pract Res Clin Anaesthesiol. 2009 Mar;23(1):69-80. Review.
Expression of Thyroid Hormone Transporters during Critical Illness. Mebis L, Paletta D, Debaveye Y, Ellger B, Langouche L, D'Hoore A, Darras V, Visser T, Van den Berghe G. Eur J Endocrinol. 2009 May 13. [Epub ahead of print]
The effect of stric blood glucose control on biliary sludge and cholestasis in critically ill patients. Mesotten D, Wauters J, Van den Berghe G, Wouters PJ, Milants I, Wilmer A. J Clin Endocrinol Metab. 2009 Apr 14. [Epub ahead of print]
Intensive insulin therapy in the intensive care unit. Van den Berghe G, Mesotten D, Vanhorebeek I. CMAJ. 2009 Mar 24.
Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Vanhorebeek I, Ellger B, De Vos R, Boussemaere M, Debaveye Y, Perre SV, Rabbani N, Thornalley PJ, Van den Berghe G. Crit Care Med. 2009 Apr;37(4):1355-64.
Ingredients for adequate evaluation of blood glucose algorithms as applied to the critically ill. Van Herpe T, De Moor B, Van den Berghe G. Crit Care. 2009;13(1):102. Epub 2009 Jan 7.
Insulin therapy in very-low-birth-weight infants.Van den Berghe G, Vlasselaers D, Vanhorebeek I. N Engl J Med. 2009 Jan 29;360(5):535; author reply 536-7. No abstract available.
Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G. Lancet. 2009 Feb 14;373(9663):547-56.
Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006832. Review.
Serial lactate measurements using microdialysis of interstitial fluid do not correlate with plasma lactate in children after cardiac surgery. van den Heuvel I, Vlasselaers D, Wouters PJ, Milants I, Ellger B, Vanhorebeek I, Van den Berghe G. Pediatr Crit Care Med. 2009 Jan;10(1):66-70.
Insulin treatment in intensive care patients.Derde S, Vanhorebeek I, Van den Berghe G. Horm Res. 2009 Jan;71(1):2-11. Epub 2008 Nov 27.
2008
Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness. Peeters RP, Hagendorf A, Vanhorebeek I, Visser TJ, Klootwijk W, Mesotten D, Wouters PJ, Koper JW, de Jong FH, Feelders RA, Lamberts SW, Van den Berghe G. Clin Endocrinol (Oxf). 2008 Oct 13.
Tight glucose control in critically ill adults. Hermans G, Schetz M, van den Berghe G. JAMA. 2008 Dec 17;300(23):2725; author reply 2726-7.
Incidence and risk factors for pressure ulcers in the intensive care unit. Nijs N, Toppets A, Defloor T, Bernaerts K, Milisen K, Van Den Berghe G. J Clin Nurs. 2008 Dec 2. [Epub ahead of print]
Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Henckaerts L, Nielsen KR, Steffensen R, Van Steen K, Mathieu C, Giulietti A, Wouters PJ, Milants I, Vanhorebeek I, Langouche L, Vermeire S, Rutgeerts P, Thiel S, Wilmer A, Hansen TK, Van den Berghe G. Crit Care Med. 2009 Jan;37(1):192-201, e1-3.
Clinical review: Critical illness polyneuropathy and myopathy. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Crit Care. 2008;12(6):238. Epub 2008 Nov 25.
Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care.Cordingley JJ, Vlasselaers D, Dormand NC, Wouters PJ, Squire SD, Chassin LJ, Wilinska ME, Morgan CJ, Hovorka R, Van den Berghe G. Intensive Care Med. 2009 Jan;35(1):123-8. Epub 2008 Jul 26.
Glycaemic control and perioperative organ protection. Berkers J, Gunst J, Vanhorebeek I, Van den Berghe G. Best Pract Res Clin Anaesthesiol. 2008 Mar;22(1):135-49. Review.
Is "safe effective glucose control" effective and safe?. Schultz MJ, Van den Berghe G. Crit Care. 2008;12(4):424; author reply 424. Epub 2008 Aug 6.
Tight glucose control in critically ill adults. Hermans G, Schetz M, van den Berghe G. JAMA. 2008 Dec 17;300(23):2725; author reply 2726-7.
Mesotten D, Vanhorebeek I, Van den Berghe G. The altered adrenal axis and treatment with glucocorticoids during critical
illness.Nat Clin Pract Endocrinol Metab. 2008 Sep;4(9):496-505.
Glucose metabolism and insulin resistance in sepsis. Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G. .Curr Pharm Des. 2008;14(19):1887-99.ss]
The importance of strict blood glucose control with insulin therapy in the
intensive care unit. van den Heuvel I, Vanhorebeek I, Van den Berghe G. .Curr Diabetes Rev. 2008 Aug;4(3):227-33.
Insulin and pentastarch for severe sepsis. Van den Berghe G, Wilmer A, Bouillon R. New England Journal of Medicine. 2008 May: vol: 358 issue: 19 pages: 2073; author reply 2074-2075.
Regulation of tissue iodothyronine deiodinase activity in prolonged critical illness. Debaveye Y, Ellger B, Mebis L, Darras V, Van den Berghe G. Thyroid. 2008 May: volume: 18 issue: 5 pages: 551-560.
Effects of Substitution and High Dose Thyroid Hormone Therapy on Deiodination, Sulfoconjugation and Tissue Thyroid Hormone Levels in Prolonged Critically Ill Rabbits. Debaveye Y, Ellger B, Mebis L, Visser TJ, Darras VM, Van den Berghe G. Endocrinology 2008 Aug;149(8):4218-28. Epub 2008 May.
Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Langouche L, Meersseman W, Vander Perre S, Milants I, Wouters P, Hermans G, Gjedsted J, Hansen TK, Arnout J, Wilmer A, Schetz M, Van den Berghe G. Critical Care Medicine. 2008 May: vol: 36 issue: 5 pages: 1475-1480.
Modulation of regional nitric oxide metabolism: blood glucose control or insulin? Ellger B, Langouche L, Richir M, Debaveye Y, Vanhorebeek I, van Leeuwen PA, Van den Berghe G. Intensive Care Medicine. 2008 Aug;34(8):1525-33. Epub 2008 Apr.
Pruritus in patients with small burn injuries. Casaer M, Kums V, Wouters PJ, Van den Kerckhove E, Van den Berghe G. Burns: journal of the International Society for Burn Injuries. 2008 Mar; vol: 34 issue: 2 pages 185-191.
Glycemic Control Modulates Arginine and Asymmetrical-Dimethylarginine Levels during Critical Illness by Preserving Dimethylarginine-Dimethylaminohydrolase Activity. Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G. Endocrinology, 2008 Jun: vol: 149 issue: 6 pages: 3148-3157. Epub 2008 Feb 21.
Tight Blood Glucose Control Is Renoprotective in Critically Ill Patients.Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G. Journal of the American Society of Nephrology. 2008 March vol: 19 issue: 571-578.
Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Van den Berghe G. Diabetologia, 2008 Jun; vol: 51 issue: 6 pages: 911-915. Epub 2007 Nov 27.
Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms. Van Herpe T, De Brabanter J, Beullens M, De Moor B, Van den Berghe G. Critical Care medicine. 2008 Feb 26; volume: 12 issue: 1: R24
Glycemic control in sepsis and septic shock: Friend or foe? Ellger B, Westphal M, Stubbe HD, Van den Heuvel I, Van Aken H, Van den Berghe G. Der Anaesthesist. 2008 Jan; vol: 57 issue: 1 pages 43-48.
2007
Validation of a continuous, arterial pressure-based cardiac output measurement: a multicenter, prospective clinical trial. McGee WT, Horswell JL, Calderon J, Janvier G, Van Severen T, Van den Berghe G, Kozikowski L. Critical Care. 2007 Sep 19, vol:11 issue 5: R105
Effect of intensive insulin therapy on insulin sensitivity in the critically ill. L. Langouche, S. Vander Perre, P. Wouters, A. D’Hoore, T. Hansen, G. Van den Berghe, The Journal of clinical endocrinology and metabolism. 2007-10-22 vol:92 issue:10 pages:3890-7,
Does intensive insulin therapy during cardiac surgery improve postoperative outcome?Van den Berghe G. Nature clinical practice. Endocrinology & metabolism. 2007 Sep; vol: 3 issue : 9 pages 630-1.
Tight blood glucose control: what is the evidence? I. Vanhorebeek, L. Langouche, G. Van den Berghe, Critical care medicine. 2007-08-22 vol:35 issue:9 Suppl pages:S496-502,
Tight blood glucose control with insulin in the ICU: facts and controversies. I. Vanhorebeek, L. Langouche, G. Van den Berghe, Chest. 2007-07-22 vol:132 issue:1 pages:268-78,
Glycemia prediction in critically ill patients using an adaptive modeling approach. Van Herpe T, Espinoza M, Haverbeke N, De Moor B, Van den Berghe G. Journal of Diabetes Science and Technology. 2007 1:348-56.
Mining data from intensive care patients. Ramon J, D. Fierens, F. Gueiza, G. Meyfroidt, H. Blockeel, M. Bruynooghe, G. Van den Berghe, Advanced engineering informatics. 2007-07 vol:21 issue:3 pages:243-256,
Indication and practical use of intensive insulin therapy in the critically ill.L. Mebis, J. Gunst, L. Langouche, I. Vanhorebeek, G. Van den Berghe, Current opinion in critical care. 2007-06-02 vol:13 issue:4 pages:392-8,
The Type II Iodothyronine Deiodinase is Upregulated in Skeletal Muscle During Prolonged Critical Illness. L. Mebis, L. Langouche, T. Visser, G. Van den Berghe, Journal of Clinical Endocrinology and Metabolism. 2007 Aug;92(8):3330-3.
Management of sepsis. Van Cromphaut S, Wilmer A, Van den Berghe G.The New England journal of medicine. 2007 Mar 15;356(11):1179-81; author reply 1181-2.
Therapy Insight: the effect of tight glycemic control in acute illness. Langouche L, Vanhorebeek I, Van den Berghe G. Nature Clinical Practice Endocrinology & Metabolism. 2007-03: 3 (3): 270-8.
Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G.American journal of respiratory and critical care medicine. 2007 Mar 1;175(5):480-9.
Monitoring blood glucose using microdialysis of the interstitial fluid in critically ill children. (letter)Vlasselaers D, Schaupp L, van den Heuvel I, Mader J, Bodenlenz M, Suppan M, Wouters PJ, Ellmerer M, Van den Berghe G. Clinical Chemistry. 2007 Mar;53(3):536-7.
Does tight blood glucose control during cardiac surgery superimposed on thight blood glucose control postoperatively in the intensive care unit improve patient outcome? (editorial) Van den Berghe G. Annals of Internal Medicine. 2007:146 (4): 307-8.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). L. Rydén, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M. de Boer, F. Cosentino, B. Jönsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir, I. Vanhorebeek, M. Stramba-Badiale, P. Lindgren, Q. Qiao, S. Priori, J. Blanc, A. Budaj, J. Camm, V. Dean, J. Deckers, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J. Tamargo, J. Zamorano, J. Deckers, M. Bertrand, B. Charbonnel, E. Erdmann, E. Ferrannini, A. Flyvbjerg, H. Gohlke, J. Juanatey, I. Graham, P. Monteiro, K. Parhofer, K. Pyörälä, I. Raz, G. Schernthaner, M. Volpe, D. Wood,European heart journal. 2007-01: vol:28 issue:1 pages:88-136,
Thyroid hormone receptor isoform expression in livers of critically ill patients. D. Thijssen-Timmer, R. Peeters, P. Wouters, F. Weekers, T. Visser, E. Fliers, W. Wiersinga, O. Bakker, G. Van den Berghe,Thyroid. 2007: issue:2 pages:105-112,
Modulating the endocrine response in sepsis: insulin and blood glucose control. Vanhorebeek I, Langouche L, Van den Berghe G. Novartis Foundation, Symposium. 2007: 280: 204-22.
Does intensive insulin therapy during cardiac surgery improve postoperative outcome? (commentary) Van den Berghe G. Nature Clinical Practice Endocrinology & Metabolism. 2007:Jul 24; [Epub ahead of print].
Tight blood glucose control with insulin in the ICU: facts and controversies. Vanhorebeek I,Langouche L, Van den Berghe G. Chest. 2007 Jul;132(1):268-78.
2006
L. Langouche, G. Van den Berghe, The dynamic neuroendocrine response to critical illness. Endocrinology and metabolism clinics of North America. 2006-12: vol:35 issue:4 pages:777-91, ix,
D. Mesotten, G. Van den Berghe, Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness. Endocrinology and metabolism clinics of North America. 2006-12: vol:35 issue:4 pages:793-805, ix-x,
L. Mebis, Y. Debaveye, T. Visser, G. Van den Berghe, Changes within the thyroid axis during the course of critical illness. Endocrinology and metabolism clinics of North America. 2006-12: vol:35 issue:4 pages:807-21, x,
I. Vanhorebeek, G. Van den Berghe, Diabetes of injury: novel insights. Endocrinology and metabolism clinics of North America. 2006-12: vol:35 issue:4 pages:859-72, x,
T. Van Herpe, M. Espinoza, B. Pluymers, I. Goethals, P. Wouters, G. Van den Berghe, B. De Moor, An adaptive input-output modeling approach for predicting the glycemia of critically ill patients. Physiological measurement. 2006-11: vol:27 issue:11 pages:1057-69,
G. Van den Berghe, First do no harm.. hypoglycemia or hyperglycemia? Critical care medicine. 2006-11: vol:34 issue:11 pages:2843-4,
Ingels C, Vanhorebeek I, Langouche L, Van den Berghe G. Rôle de l’insuline et du contrôle de la glycémie en réanimation. Réanimation. 2006: 15: 474-480.
C Ingels, Y. Debaveye, I. Milants, E. Buelens, A. Peeraer, Y. Devriendt, T. Vanhoutte, A. Van Damme, M. Schetz, P. Wouters, G. Van den Berghe, Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. European heart journal. 2006-11: vol:27 issue:22 pages:2716-24,
I. Vanhorebeek, R. Peeters, S. Vander Perre, I. Jans, P. Wouters, K. Skogstrand, T. Hansen, R. Bouillon, G. Van den Berghe, Cortisol response to critical illness: effect of intensive insulin therapy. The Journal of clinical endocrinology and metabolism. 2006-10: vol:91 issue:10 pages:3803-13,
Vanhorebeek I, Langouche L, Van den Berghe G. Behoud van normale bloedsuikerspiegels met intensieve insulinetherapie bij kritiek zieken. Tijdschrift voor Geneeskunde. 2006: 62: 1011-1017.
G. Van den Berghe, P. Wilmer, I. Milants, P. Wouters, B. Bouckaert, F. Bruyninckx, R. Bouillon, M. Schetz, Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006-10: vol:55 issue:11 pages:3151-9,
I. Vanhorebeek, L. Langouche, G. Van den Berghe. Intensive insulin therapy in the intensive care unit: update on clinical impact and mechanisms of action, Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2006-07: vol:12 Suppl 3 pages:14-22,
H. Lochs, S. Allison, R. Meier, M. Pirlich, J. Kondrup, S. Schneider, G. Van den Berghe, C. Pichard, Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, definitions and general topics. Clinical nutrition (Edinburgh, Scotland) 2006-04: vol:25 issue:2 pages:180-6,
Langouche L, Vanhorebeek I, Van den Berghe G. Glycaemic control in trauma patients, is there a role? Trauma. 2006: 8: 13-19.
K. Kreymann, M. Berger, N. Deutz, M. Hiesmayr, P. Jolliet, G. Kazandjiev, G. Nitenberg, G. Van den Berghe, J. Wernerman, C. Ebner, W. Hartl, C. Heymann, C. Spies, ESPEN Guidelines on Enteral Nutrition: Intensive care. Clinical nutrition (Edinburgh, Scotland). 2006-04: vol:25 issue:2 pages:210-23,
B. Ellger, Y. Debaveye, I. Vanhorebeek, L. Langouche, A. Giulietti, E. van Etten, P. Herijgers, C. Mathieu, G. Van den Berghe, Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006-04: vol:55 issue:4 pages:1096-105,
P. Devos, R. Chioléro, G. Van den Berghe, J. Preiser, Glucose, insulin and myocardial ischaemia. Current opinion in clinical nutrition and metabolic care. 2006-03: vol:9 issue:2 pages:131-9,
G. Van den Berghe, P. Wouters, K. Kesteloot, D. Hilleman, Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Critical care medicine. 2006-03: vol:34 issue:3 pages:612-6,
G. Van den Berghe, P. Wilmer, G. Hermans, W. Meersseman, P. Wouters, I. Milants, E. Van Wijngaerden, H. Bobbaers, R. Bouillon, Intensive insulin therapy in the medical ICU., The New England journal of medicine. 2006 Feb 2;354(5):449-61,
I. Vanhorebeek, G. Van den Berghe, The neuroendocrine response to critical illness is a dynamic process. Critical care clinics. 2006-01: vol:22 issue:1 pages:1-15, v,
D. Mesotten, G. Van den Berghe, Changes within the GH/IGF-I/IGFBP axis in critical illness. Critical care clinics. 2006-01: vol:22 issue:1 pages:17-28, v,
L. Langouche, G. Van den Berghe, Glucose metabolism and insulin therapy. Critical care clinics. 2006-01/ vol:22 issue:1 pages:119-29, vii,
I. Vanhorebeek, L. Langouche, G. Van den Berghe, Endocrine aspects of acute and prolonged critical illness. Nature clinical practice. Endocrinology & metabolism. 2006-01: vol:2 issue:1 pages:20-31,
Van den Berghe G. Endocrinology of critical illness. Critical Care Clinics. 2006: 22: XI-XII.
Y. Debaveye, G. Van den Berghe, Risks and benefits of nutritional support during critical illness. Annual review of nutrition. 2006-01: vol:26 pages:513-38,
R. Peeters, Y. Debaveye, E. Fliers, T. Visser, Changes within the thyroid axis during critical illness. Critical care clinics. 2006-01: vol:22 issue:1 pages:41-55, vi,
Van Herpe T, Pluymers B, Espinoza M, Van den Berghe G, and De Moor B. A minimal model for glycemia control in critically ill patients. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2006;1:5432-5.
Vanhorebeek I, Ingels C, Van den Berghe G. Intensive insulin therapy in high-risk cardiac surgery patients: evidence from the Leuven randomized study. Seminars in Thoracic and Cardiovascular Surgery. 2006: 18 (4): 309-16.
2000-2005
Gauna C, Van den Berghe G, van der Lely AJ. Pituitary function during severe and life-threatening illnesses. Pituitary. 2006: 8(3-4):213-7.
Quaghebeur B, Van Gelder F, Daenen W, Van den Berghe G. Potential for HB and NHB organ donation: A retrospective medical record review on 7 critical care units in a 1900 bed hospital. American Journal of Transplantation. 2005: 5: 373– abstract 854 suppl.
M. Schetz, G. Van den Berghe, Do we have reliable biochemical markers to predict the outcome of critical illness? The International journal of artificial organs. 2005-12: vol:28 issue:12 pages:1197-210,
Y. Debaveye, B. Ellger, L. Mebis, E. Van Herck, W. Coopmans, V. Darras, G. Van den Berghe, Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. Endocrinology. 2005-12: vol:146 issue:12 pages:5604-11,
R. Peeters, M. Kester, P. Wouters, E. Kaptein, H. van Toor, T. Visser, G. Van den Berghe, Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity. The Journal of clinical endocrinology and metabolism. 2005-12: vol:90 issue:12 pages:6460-5,
R. Peeters, S. Van der Geyten, P. Wouters, V. Darras, H. van Toor, E. Kaptein, T. Visser, G. Van den Berghe, Tissue thyroid hormone levels in critical illness. The Journal of clinical endocrinology and metabolism. 2005-12: vol:90 issue:12 pages:6498-507,
I. Vanhorebeek, L. Langouche, G. Van den Berghe, Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness? Current opinion in critical care. 2005-08: vol:11 issue:4 pages:304-11,
L. Langouche, I. Vanhorebeek, D. Vlasselaers, S. Vander Perre, P. Wouters, K. Skogstrand, T. Hansen, G. Van den Berghe, Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of clinical investigation. 2005-08: vol:115 issue:8 pages:2277-86,
R. Peeters, P. Wouters, H. van Toor, E. Kaptein, T. Visser, G. Van den Berghe, Serum 3,3’,5’-triiodothyronine (rT3) and 3,5,3’-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. The Journal of clinical endocrinology and metabolism. 2005-08: vol:90 issue:8 pages:4559-65,
G. Van den Berghe, Insulin vs. strict blood glucose control to achieve a survival benefit after AMI? European heart journal. 2005-04: vol:26 issue:7 pages:639-41,
B. Ellger, Y. Debaveye, G. Van den Berghe, Endocrine interventions in the ICU. European journal of internal medicine. 2005-04: vol:16 issue:2 pages:71-82,
G. Van den Berghe, K. Schoonheydt, P. Becx, F. Bruyninckx, P. Wouters, Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005-04: vol:64 issue:8 pages:1348-53,
M. Siroen, P. van Leeuwen, R. Nijveldt, T. Teerlink, P. Wouters, G. Van den Berghe, Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Critical care medicine. 2005-03: vol:33 issue:3 pages:504-10,
L. Langouche, I. Vanhorebeek, G. Van den Berghe, The role of insulin therapy in critically ill patients. Treatments in endocrinology. 2005-01: vol:4 issue:6 pages:353-60,
I. Vanhorebeek, R. De Vos, D. Mesotten, P. Wouters, C. De Wolf-Peeters, G. Van den Berghe, Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005: vol:365 pages:53-59,
Ellger B, Debaveye Y, Van den Berghe G. Endokrinologie der Intensivmedizin. Intensivmedizin up2date. 2005: 1: 313-28.
Van den Berghe G. Treatment of critical care patients with substantial acute ischemic or traumatic brain injury – Reply. Critical Care Medicine. 2005: 33 (9): 2149–2149.
Van den Berghe G. Maintenance of euglycemia with insulin in ICU patients. Shock. 2004: 21: 85-85.
I. Vanhorebeek, G. Van den Berghe, Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Current opinion in pharmacology. 2004-12: vol:4 issue:6 pages:621-8,
G. Van den Berghe, How does blood glucose control with insulin save lives in intensive care? The Journal of clinical investigation. 2004-11: vol:114 issue:9 pages:1187-95,
G. Van den Berghe, Tight blood glucose control with insulin in “real-life” intensive care. Mayo Clinic proceedings. Mayo Clinic. 2004-08: vol:79 issue:8 pages:977-8,
F. Weekers, G. Van den Berghe, Endocrine modifications and interventions during critical illness. The Proceedings of the Nutrition Society. 2004-08: vol:63 issue:3 pages:443-50,
D. Mesotten, P. Wouters, R. Peeters, K. Hardman, J. Holly, R. Baxter, G. Van den Berghe, Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. The Journal of clinical endocrinology and metabolism. 2004-07: vol:89 issue:7 pages:3105-13,
G. Van den Berghe, How to compare adequacy of algorithms to control blood glucose in the intensive care unit? Critical care (London, England). 2004-06: vol:8 issue:3 pages:151-2,
G. Van den Berghe, Role of intravenous insulin therapy in critically ill patients. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2007-02: vol:10 Suppl 2 pages:17-20,
Garber AJ, Moghissi ES, Brandsome ED, Clarck NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V. 2004 American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocrine Practice. 2004 Mar-Apr;10 Suppl 2:4-9.
G. Van den Berghe, R. Bouillon, Optimal control of glycemia among critically ill patients. JAMA: the journal of the American Medical Association. 2004-03: vol:291 issue:10 pages:1198-9,
Y. Debaveye, G. Van den Berghe, Is there still a place for dopamine in the modern intensive care unit? Anesthesia and analgesia. 2004-02: vol:98 issue:2 pages:461-8,
Garber AJ, Moghissi ES, Brandsome ED, Clarck NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V. 2004 American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocrine Practice. 2004 Jan-Feb;10(1):77-82
M. Schetz, G. Van den Berghe, Glucose control in the critically ill. Contributions to nephrology. 2004-01: vol:144 pages:119-31,
D. Mesotten, G. Van den Berghe, Mechanisms of insulin-induced alterations in metabolism during critical illness. Nestlé Nutrition workshop series. Clinical & performance programme. 2004-01: vol:9 pages:69-75,
F. Weekers, M. Michalaki, W. Coopmans, E. Van Herck, J. Veldhuis, V. Darras, G. Van den Berghe, Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology. 2004-01: vol:145 issue:1 pages:205-13,
D. Mesotten, J. Swinnen, F. Vanderhoydonc, P. Wouters, G. Van den Berghe, Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. The Journal of clinical endocrinology and metabolism. 2004-01: vol:89 issue:1 pages:219-26,
Van den Berghe G. Insulin therapy in critical illness. Canadian Journal of Diabetes. 2004: i28: 43–49.
Van den Berghe G, Bouillon R. (correspondence) Optimal control of glycemia among critically ill patients. JAMA. 2004: 291: 1198–1199.
Van den Berghe G. How to compare adequacy of algorithms to control blood glucose in the ICU? (invited commentary) Critical Care. 2004: 8: 151–152.
Debaveye Y, Van den Berghe G. (correspondence) Reply to “Let us not displace small-dose dopamine from the modern ICU so soon”. Anesthesia & Analgesia. 2004: 99: 947–957.
F. Weekers, A. Giulietti, M. Michalaki, W. Coopmans, E. Van Herck, C. Mathieu, G. Van den Berghe, Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003-12: vol:144 issue:12 pages:5329-38,
G. Van den Berghe, D. Van Roosbroeck, P. Vanhove, P. Wouters, L. De Pourcq, R. Bouillon, Bone turnover in prolonged critical illness: effect of vitamin D. The Journal of clinical endocrinology and metabolism. 2003-10: vol:88 issue:10 pages:4623-32,
D. Mesotten, G. Van den Berghe, C. Liddle, S. Coulter, F. McDougall, R. Baxter, P. Delhanty, Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. Endocrinology. 2003-09: vol:144 issue:9 pages:4008-17,
R. Peeters, P. Wouters, E. Kaptein, H. van Toor, T. Visser, G. Van den Berghe, Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. The Journal of clinical endocrinology and metabolism. 2003-07: vol:88 issue:7 pages:3202-11,
G. Van den Berghe, Endocrine evaluation of patients with critical illness. Endocrinology and metabolism clinics of North America. 2003-06: vol:32 issue:2 pages:385-410,
T. Hansen, S. Thiel, P. Wouters, J. Christiansen, G. Van den Berghe, Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. The Journal of clinical endocrinology and metabolism. 2003-03: vol:88 issue:3 pages:1082-8,
G. Van den Berghe, P. Wouters, R. Bouillon, F. Weekers, C. Verwaest, M. Schetz, D. Vlasselaers, P. Ferdinande, P. Lauwers, Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Critical care medicine. 2003-02: vol:31 issue:2 pages:359-66,
G. Van den Berghe, Insulin therapy for the critically ill patient. Clinical cornerstone. 2003-01: vol:5 issue:2 pages:56-63,
D. Mesotten, G. Van den Berghe, Clinical potential of insulin therapy in critically ill patients. Drugs. 2003-01: vol:63 issue:7 pages:625-36,
M. Casaer, C. Ingels, K. Engelen, M. Valcke, G. Van den Berghe, The Leuven “failure to extubate study”: Propofol as an independent risk factor after cardiac surgery. Intensive care medicine. 2003: vol:29 pages:S131-S131,
Van den Berghe G. Intensive insulin therapy in the ICU. Indian Journal of Critical Care Medicine. 2003: 7: 106-111.
Van den Berghe G. (correspondence) The author replies: Insulin dose or glycemic control for the critically ill? Critical Care Medicine. 2003: 31: 2565–2566.
D. Mesotten, P. Delhanty, F. Vanderhoydonc, K. Hardman, F. Weekers, R. Baxter, G. Van den Berghe, Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. The Journal of clinical endocrinology and metabolism. 2002-12: vol:87 issue:12 pages: 5516-23,
J. Vincent, E. Abraham, D. Annane, G. Bernard, E. Rivers, G. Van den Berghe, Reducing mortality in sepsis: new directions. Critical care (London, England). 2002-12: vol:6 Suppl 3 pages:S1-18,
G. Van den Berghe, Dynamic neuroendocrine responses to critical illness. Frontiers in neuroendocrinology. 2002-10: vol:23 issue:4 pages:370-91,
J. Preiser, P. Devos, G. Van den Berghe, Tight control of glycaemia in critically ill patients. Current opinion in clinical nutrition and metabolic care. 2002-09: vol:5 issue:5 pages:533-7,
G. Van den Berghe, Beyond diabetes: saving lives with insulin in the ICU. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 2002-09: vol:26 Suppl 3 pages:S3-8,
G. Van den Berghe, Neuroendocrine pathobiology of chronic critical illness. Critical care clinics. 2002-07: vol:18 issue:3 pages:509-28,
G. Van den Berghe, R. Baxter, F. Weekers, P. Wouters, C. Bowers, A. Iranmanesh, J. Veldhuis, R. Bouillon, The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clinical endocrinology. 2002-05: vol:56 issue:5 pages:655-69,
F. Weekers, E. Van Herck, W. Coopmans, M. Michalaki, C. Bowers, J. Veldhuis, G. Van den Berghe, A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology. 2002-03: vol:143 issue:3 pages:764-74,
G. Van den Berghe, S. Shalet, Critical illness as a model of hypothalamic ageing. Novartis Foundation symposium. 2002-01: vol:242 pages:205-15; discussion 216-21.
G. Van den Berghe, Endocrinology in intensive care medicine: new insights and therapeutic consequences. Verhandelingen - Koninklijke Academie voor Geneeskunde van België. 2002-01: vol:64 issue:3 pages:167-87; discussion 187-8.
Van den Berghe G. Insulin therapy in critical illness. Diabetes Monitor. 2002: 14: 1-6.
Van den Berghe G. The Sepsis Text (invited Book Review). New England Journal of Medicine. 2002: 347: 1213-1214.
Van den Berghe G, Bouillon R, Lauwers P. Intensive Insulin Therapy in Critically Ill Patients (correspondence). New England Journal of Medicine. 2002: 346: 1586–1588.
G. Van den Berghe, The neuroendocrine response to stress is a dynamic process. Best practice & research. Clinical endocrinology & metabolism. 2001-12: vol:15 issue:4 pages:405-19,
G. Van den Berghe, P. Wouters, F. Weekers, C. Verwaest, F. Bruyninckx, M. Schetz, D. Vlasselaers, P. Ferdinande, P. Lauwers, R. Bouillon, Intensive insulin therapy in the critically ill patients. The New England journal of medicine. 2001-10: vol:345 issue:19 pages:1359-67,
Christiansen JS, Bengtsson BA, Thorner MO, Hintz R, Sonksen PH, Cohen P, Clemmons D, Strasburegr CJ, Carlson L, Tanaka T, Robinson I, Jorgtenson JO, Johannson G, Clayton PE, Cowell CT, Malozowski SN, Hankinson S, Yee D, Baxtre R, Swerdlow A, Rosenfeld R, Fradkin JE, Nishi Y, Monson JP, Van den Berghe G, Carroll PV, Takala J, Van der Lely AJ, Pollak MN, LeRoith D, Tachibana K, Kappelgaard AM, Langbakke I, Lippe B, Wilton P, Stein P, Salazar DE, Maneatis T, Blethen SL, Cutler G, Blum W, Svanberg E, Gertner JM, Shimatsu A, Takahashi H. Critical Evaluation of the safety of recombinant human growth hormone administration : statement from the growth hormone research society. Journal of Clinical Endocrinology and Metabolism. 2001: 86: 1868–1870.
G. Van den Berghe, F. Weekers, R. Baxter, P. Wouters, A. Iranmanesh, R. Bouillon, J. Veldhuis, Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. The Journal of clinical endocrinology and metabolism. 2001-07: vol:86 issue:7 pages:3217-26,
P. Carroll, G. Van den Berghe, Safety aspects of pharmacological GH therapy in adults. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 2001-06: vol:11 issue:3 pages:166-72,
G. Van den Berghe, Bad news about growth hormone treatment in the intensive care unit: need for some clarification. Current opinion in anaesthesiology. 2001-04: vol:14 issue:2 pages:127-9,
G. Van den Berghe, Molecular biology: a timely tool for further unraveling the “diabetes of stress”. Critical care medicine. 2001-04: vol:29 issue:4 pages:910-1,
Van den Berghe G. The neuroendocrine axis in critical illness. Current Opinion in Endocrinology and Diabetes. 2001: 8: 47–54.
Van den Berghe G. Endocrinology in critical care medicine – Preface.
Baillieres Best Practice and Research in Endocrinology and Metabolism. 2001: 15: VII-VII.
F. Weekers, E. Van Herck, J. Isgaard, G. Van den Berghe, Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model. Endocrinology. 2000-11: vol:141 issue:11 pages:3993-9,
G. Van den Berghe, Novel insights into the neuroendocrinology of critical illness. European journal of endocrinology / European Federation of Endocrine Societies. 2000-07: vol:143 issue:1 pages:1-13,
G. Van den Berghe, Euthyroid sick syndrome. Current opinion in anaesthesiology. 2000-041: vol:13 issue:2 pages:89-91,
G. Van den Berghe, R. Baxter, F. Weekers, P. Wouters, C. Bowers, J. Veldhuis, A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. The Journal of clinical endocrinology and metabolism. 2000-01: vol:85 issue:1 pages:183-92,
G. Van den Berghe, Increased mortality associated with growth hormone treatment in critically ill adults. The New England journal of medicine. 2000-01: vol:342 issue:2 pages:135; author reply 135-6,
Van den Berghe G. Pituitary function in the critically ill patient. International Growth Monitor. 2000: 10: 2–7.
before 2000
G. Van den Berghe, Endocrine changes in critically ill patients. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 1999-04: vol:9 Suppl A pages:77-81,
Van den Berghe G. The neuroendocrine stress response and modern intensive care: the concept revisited. Burns. 1999 Feb;25(1):7-16.
G. Van den Berghe, P. Wouters, F. Weekers, S. Mohan, R. Baxter, J. Veldhuis, C. Bowers, R. Bouillon, Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. The Journal of clinical endocrinology and metabolism. 1999-04: vol:84 issue:4 pages:1311-23,
G. Van den Berghe, Growth hormone secretagogues in critical illness. Hormone research. 1999-01: vol:51 Suppl 3 pages:21-8,
G. Van den Berghe, P. Wouters, C. Bowers, F. de Zegher, R. Bouillon, J. Veldhuis, Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. European journal of endocrinology / European Federation of Endocrine Societies. 1999-01: vol:140 issue:1 pages:17-22,
Van den Berghe G. (Editorial) Whither growth hormone in the catabolic state of critical illness? Growth Hormone & IGF Research. 1999: 9: 397–399.
G. Van den Berghe, P. Wouters, L. Carlsson, R. Baxter, R. Bouillon, C. Bowers, Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone. The Journal of clinical endocrinology and metabolism. 1998-09: vol:83 issue:9 pages:3062-70,
G. Van den Berghe, F. de Zegher, R. Bouillon, Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. The Journal of clinical endocrinology and metabolism. 1998-06: vol:83 issue:6 pages:1827-34,
G. Van den Berghe, F. de Zegher, R. Bouillon, The somatotrophic axis in critical illness: effects of growth hormone secretagogues. Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society. 1998-04: vol:8 Suppl B pages:153-5,
G. Van den Berghe, F. de Zegher, R. Baxter, J. Veldhuis, P. Wouters, M. Schetz, C. Verwaest, E. Van der Vorst, P. Lauwers, R. Bouillon, C. Bowers, Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. The Journal of clinical endocrinology and metabolism. 1998-02: vol:83 issue:2 pages:309-19,
de Zegher F, Spitz B, Van den Berghe G, Lemmens D, Vanweser K, Keppens K, Bowers CY.Postpartum hyperprolactinemia and hyporesponsiveness of growth hormone (GH) to GH-releasing peptide. Journal of Clinical Endocrinology and Metabolism 1998 Jan;83(1):103-6
Van den Berghe G. Acute and prolonged critical illness are two distinct neuroendocrine paradigms. Verhandelingen van de Koninklijke Academie voor Geneeskunde van België. 1998: LX nr. 6: 487–520.
de Zegher F, Vanhole C, Van den Berghe G, Christiaens B, Devlieger H, Spitz B. 1997 Thyroid function 6 years after prenatal treatment with TRH. Pediatrics. 1997 Dec;100(6):1042-3
G. Van den Berghe, F. de Zegher, J. Veldhuis, P. Wouters, S. Gouwy, W. Stockman, F. Weekers, M. Schetz, P. Lauwers, R. Bouillon, C. Bowers, Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clinical endocrinology. 1997-11: vol:47 issue:5 pages:599-612,
de Zegher F, Francois I, Van Helvoirt M, Van den Berghe G. Small as fetus and short as child - from endogenous to exogenous growth hormone. Journal of Clinical Endocrinology and Metabolism. 1997 Jul;82(7):2021-6.
Vanhole C, Aerssens P, Naulaers G, Casneuf A, Devlieger H, Van den Berghe G, de Zegher F. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatric Research. 1997 Jul;42(1):87-92
G. Van den Berghe, F. de Zegher, J. Veldhuis, P. Wouters, M. Awouters, W. Verbruggen, M. Schetz, C. Verwaest, P. Lauwers, R. Bouillon, C. Bowers, The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. The Journal of clinical endocrinology and metabolism. 1997-02: vol:82 issue:2 pages:590-9,
C. Verwaest, J. Verhaegen, P. Ferdinande, M. Schetz, G. Van den Berghe, L. Verbist, P. Lauwers, Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Critical care medicine. 1997-01: vol:25 issue:1 pages:63-71,
G. Van den Berghe, F. de Zegher, C. Bowers, P. Wouters, P. Muller, F. Soetens, D. Vlasselaers, M. Schetz, C. Verwaest, P. Lauwers, R. Bouillon, Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Clinical endocrinology. 1996-09: vol:45 issue:3 pages:341-51,
G. Van den Berghe, F. de Zegher, Anterior pituitary function during critical illness and dopamine treatment. Critical care medicine. 1996-09: vol:24 issue:9 pages:1580-90,
G. Van den Berghe, F. de Zegher, D. Vlasselaers, M. Schetz, C. Verwaest, P. Ferdinande, P. Lauwers, Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. Critical care medicine. 1996-04: vol:24 issue:4 pages:590-5,
Van den Berghe G, de Zegher F. A senescent pattern of pituitary function in critical illness and dopamine treatment. Verhandelingen van de Koninklijke Academie voor Geneeskunde van België. 1996: LVIII nr. 4, 383–411.
de Zegher F, Pernasetti F, Van Hole C, Devlieger H, Van den Berghe G, Martial JA. 1995 The prenatal role of thyroid hormone evidenced by feto-maternal Pit-1 deficiency.
Journal of Clinical Endocrinology and Metabolism. 1995 Nov;80(11):3127-30
G. Van den Berghe, F. de Zegher, P. Wouters, M. Schetz, C. Verwaest, P. Ferdinande, P. Lauwers, Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clinical endocrinology. 1995-10: vol:43 issue:4 pages:457-63,
de Zegher F, Kaplan SL, Grumbach MM, Van den Berghe G, Francois I, Vanhole C, Devlieger H. The fetal pituitary, postmaturity and breech presentation. Acta Pediatrica. 1995 Oct;84(10):1100-2.
M. Schetz, P. Ferdinande, G. Van den Berghe, C. Verwaest, P. Lauwers, Pharmacokinetics of continuous renal replacement therapy. Intensive care medicine. 1995-07: vol:21 issue:7 pages:612-20,
H. Demuynck, P. Zachée, G. Verhoef, M. Schetz, G. Van den Berghe, P. Lauwers, M. Boogaerts, Risks of rhG-CSF treatment in drug-induced agranulocytosis. Annals of hematology. 1995-03: vol:70 issue:3 pages:143-7,
M. Schetz, P. Ferdinande, G. Van den Berghe, C. Verwaest, P. Lauwers, Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive care medicine. 1995-02: vol:21 issue:2 pages:169-76,
G. Van den Berghe, F. de Zegher, P. Lauwers, Dopamine and the sick euthyroid syndrome in critical illness. Clinical endocrinology. 1994-12: vol:41 issue:6 pages:731-7,
G. Van den Berghe, F. de Zegher, P. Lauwers, Dopamine suppresses pituitary function in infants and children. Critical care medicine. 1994-11: vol:22 issue:11 pages:1747-53,
G. Van den Berghe, F. de Zegher, P. Lauwers, J. Veldhuis, Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine. Clinical endocrinology. 1994-11: vol:41 issue:5 pages:563-9,
G. Van den Berghe, M. Vandaele, H. Demeyer, Accurate high-lying eigenvalues of schrodinger and sturm-liouville problems. Physics letters a. 1994-10: vol:193 issue:4 pages:341-347,
G. Van den Berghe, F. de Zegher, P. Lauwers, J. Veldhuis, Growth hormone secretion in critical illness: effect of dopamine. The Journal of clinical endocrinology and metabolism. 1994-10: vol:79 issue:4 pages:1141-6,
de Zegher F, Van Hole C, Van den Berghe G, Devlieger H, Eggermont E, Veldhuis JD. Properties of thyroid stimulating hormone and cortisol secretion by the human newborn on the day of birth. Journal of Clinical Endocrinology and Metabolism. 1994 Aug;79(2):576-81.
de Zegher F, Van den Berghe G, Dumoulin M, Gewillig M, Daenen W, Devliegher H. Dopamine suppresses thyroid-stimulating hormone in neonatal hypothyroidism. Acta Pediatrica. 1994: 84: 213–214.
van den Berghe G, de Zegher F, Vanhaecke J, Verleden G, Lauwers P. Growth hormone as a rescue treatment after heart-lung or double lung transplantation. Endocrinology and Metabolism. 1994: 1: 187–190.
de Zegher F, Van den Berghe G, Devlieger H, Eggermont E, Veldhuis JD. Dopamine inhibits growth hormone and prolactin secretion in thehuman newborn. Pediatric Research. 1993 Nov;34(5):642-5.
